Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer
Introduction: Even in times of new therapy regimes, the overall survival of patients with head and neck cancer remains low. Since the previous studies showed the beneficial effect of metformin medication on the survival of patients with cancer, our objective was to investigate if—and in which way—me...
Main Authors: | Florian Gaertner, Saskia Preissner, Max Heiland, Robert Preissner, Jonas Wüster |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/5/982 |
Similar Items
-
Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients
by: Jonas Wüster, et al.
Published: (2023-06-01) -
Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment
by: Venu Gopal Jonnalagadda, et al.
Published: (2018-09-01) -
Synergistic Effects of Omeprazole and Metformin on Glycemic Control in Type 2 Diabetic Patients. A Randomized Clinical Study
by: Fizzah Ali, et al.
Published: (2017-04-01) -
Synergistic Effects of Omeprazole and Metformin on Glycemic Control in Type 2 Diabetic Patients. A Randomized Clinical Study
by: Fizzah Ali, et al.
Published: (2017-04-01) -
Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
by: Laith N. AL-Eitan, et al.
Published: (2019-03-01)